Rennova Health (OTCMKTS:RNVA) versus iRhythm Technologies (NASDAQ:IRTC) Head to Head Contrast

iRhythm Technologies (NASDAQ:IRTC) and Rennova Health (OTCMKTS:RNVA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Risk & Volatility

iRhythm Technologies has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Rennova Health has a beta of 19.68, indicating that its share price is 1,868% more volatile than the S&P 500.

Profitability

This table compares iRhythm Technologies and Rennova Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-14.06%	-90.03%	-8.52%
Rennova Health	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings for iRhythm Technologies and Rennova Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	0	2	10	1	2.92
Rennova Health	0	0	0	0	0.00

iRhythm Technologies currently has a consensus price target of $167.50, indicating a potential downside of 2.61%. Given Rennova Health’s higher possible upside, analysts clearly believe Rennova Health is more favorable than iRhythm Technologies.

Valuation & Earnings

This table compares iRhythm Technologies and Rennova Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$657.23 million	8.41	-$113.29 million	($2.93)	-58.70
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A

Rennova Health has lower revenue, but higher earnings than iRhythm Technologies.

Summary

Rennova Health beats iRhythm Technologies on 6 of the 10 factors compared between the two stocks.

About iRhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.